liraglutide semaglutide tirzepatide Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and # liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Tirzepatide vs semaglutide and liraglutide

Larger studies with standardized treatment approaches and strict lifestyle modification monitoring are needed to confirm these findings.

Physician-supervised treatments designed to help you lose weight safely and feel your best.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist , primarily used to manage Type 2 diabetes and facilitate weight loss in individuals who are overweight or have obesity-related health conditions

TRANSCEND-T2D-1: Retatrutide in adults with obesity and type 2 diabetes

Evidence-based comparison of semaglutide (Wegovy/Ozempic) and zovaglutide (QL Biopharm), examining weekly vs monthly GLP-1 dosing frequency, STEP vs Phase 2 data, and the clinical implications of once-monthly injection.